Eric Olson

(Mr. Eric Olson Ph.D.)

Currently holds a position at Syros Pharmaceuticals Inc

Positions
Position Company Period
Chief Scientific Officer Syros Pharmaceuticals Inc April 1, 2013 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-07-18 2023-07-17
PS Planned sale
689 -9.4%
3.50
2,412 USD 		689 -9.4% 3.50 2,412 USD
2022-01-06 2022-01-05
PS Planned sale
2,208 -100.0%
3.47
7,655 USD 		2,208 -100.0% 3.47 7,655 USD
2021-03-17 2021-03-15
PS Planned sale
3,628 -100.0%
9.47
34,372 USD 		3,628 -100.0% 9.47 34,372 USD
2020-08-19 2020-08-18
PS Planned sale
10,787 -100.0%
13.00
140,231 USD 		10,787 -100.0% 13.00 140,231 USD
2020-08-19 2020-08-17
PS Planned sale
4,963 -100.0%
13.00
64,519 USD 		4,963 -100.0% 13.00 64,519 USD
2020-07-07 2020-07-07
PS Planned sale
1,753 -100.0%
11.72
20,538 USD 		1,753 -100.0% 11.72 20,538 USD
2020-02-20 2020-02-18
PS Planned sale
1,446 -100.0%
7.38
10,674 USD 		1,446 -100.0% 7.38 10,674 USD